Opipramol for the treatment of generalized anxiety disorder: A placebo-controlled trial including an alprazolam-treated group

Journal of Clinical Psychopharmacology

Volumn 21, Issue 1, 2001, Pages 59-65

  Möller, Hans Jorgen ^a   Volz, Hans Peter ^b   Reimann, Ingrid W ^c,d   Stoll, Klaus Dieter ^e  

^a UNIVERSITY OF MUNICH   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c Medical Department ^*

^d Medical Department   (Germany)

^e Novartis GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; OPIPRAMOL; PLACEBO;

ADULT; ANXIETY NEUROSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; SINGLE BLIND PROCEDURE; SLEEP DISORDER; TIBIA FRACTURE; TRANQUILIZING ACTIVITY; VERTIGO;

ADOLESCENT; ADULT; AGED; ALPRAZOLAM; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; OPIPRAMOL; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 0035142359     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200102000-00011     Document Type: Article

References (27)

1. Antidepressants for the treatment of generalized anxiety disorder: A placebo-controlled comparison of imipramine, trazodone, and diazepam
2. Differential effects of alprazolam and imipramine in generalized anxiety disorder: Somatic versus psychic symptoms
3. A study of opipramol in general practice
4. Undersökning med Endison pa allmänpraktiskt neuroklientel
5. Sequential double blind controlled trial of opipramol in anxiety neurosis
6. A comparison between diazepam, dixyrazine, opipramol and placebo in anxiety states
7. Incidencias de los psicofarmacos en la evolucion rheumatologica del enfermo poliartritico cronico
8. Drug treatment of anxiety: A controlled study of opipramol and chlordiazepoxide
9. A comparison of the therapeutic effect of insidon and meprobamate in neurotic women
10. Opipramol and trifluoperazine in the treatment of anxiety and tension
11. A double-blind comparison of opipramol and diazepam in the treatment of anxiety in general practice
12. A comparative trial of insidon and stelazine in the treatment of anxiety
13. A comparative trial of opipramol and chlordiazepoxide in the treatment of anxiety
14. In vivo (3H) spiperone binding to the rat hippocampal formation: Involvement of dopamine receptors
15. The D-1 dopamine receptor antagonist SCH 23 390 also interacts potently with brain serotonin (5-HT2) receptors
16. Blockade of hippocampal dopamine (DA) receptors: A tool for antipsychotics with low extrapyramidal side effects
17. Mesohippocampal dopamine system. Characterisation, functional and clinical implications
18. Detection of dopamine receptors in homogenates of rat hippocampus and other brain areas
19. Neurochemical characterisation of dopaminergic effects of opipramol, a potent sigma receptor ligand, in vivo
20. Opipramol, a potent sigma ligand, is an anti-ischemic agent: Neurochemical evidence for an interaction with the N-methyl-D-aspartate receptor complex in vivo by cerebellar cGMP measurements
21. 3H]opipramol labels a novel binding site and σ receptors in rat brain membranes
22. Opipramol im vergleich zu anderen therapeutika - Neue pharmakologische daten
23. Routine psychiatric examinations guided by ICD-10 Diagnostic Checklists (International Diagnostic Checklists)
24. Opipramol for the treatment of somatoform disorders - Results from a placebo-controlled trial